Global Glucoamylase Powder Market Strategic Research Report
By Type: Type I (Low Debranching) Glucoamylase Powder, Type II (High Debranching) Glucoamylase Powder
By Application: Feed, Food, Brewing, Other
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Enzyme Development Corporation (Unlisted, New York USA), Creative Enzymes (Unlisted, New York USA), Enzyme Innovation (Unlisted, Chino California USA), Murphy & Son Ltd (Unlisted, Nottingham UK), Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China), Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China), Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China), Sunsonzyme (Unlisted, Beijing China), Henan Yangshao Bio-Engineering Co., Ltd. (Unlisted, Henan China), Longchang Chemical Co., Ltd. (Unlisted, Shandong China)
Обзор
Scope of the Report
The global Glucoamylase Powder market size is predicted to grow from US$ 313 million in 2025 to US$ 360 million in 2032; it is expected to grow at a CAGR of 2.1% from 2026 to 2032.
Glucoamylase powder is a solid formulation developed to meet the needs of long-term storage and transportation, dry formulation, and high-temperature processes. It solves the core bottlenecks of liquid enzymes, such as poor stability, high cost, and inconvenient application in tropical storage, long-distance logistics, solid feed premix production, and certain industrial processes requiring direct mixing with dry materials. The upstream supply chain focuses on the breeding of high-yield strains and the supply of solid-state fermentation raw materials such as starch and bran. Downstream, it primarily connects with feed additives requiring solid formulations, some food premixes, brewing and starch sugar factories in remote areas, and export trade. By integrating into customers' solid processing procedures or overcoming harsh storage and transportation conditions, it solves the problems of stability, economy, and convenience in enzyme supply for specific application scenarios, forming a unique supply chain from "strains and agricultural products → solid-state fermentation/drying → solid industrial applications and global distribution." In 2025, the production of glucosylase powder is estimated at approximately 40,000 tons, with an average price of approximately US$8/kg, a gross profit margin of approximately 30%, and a single-line capacity of 500 tons/year.
Global key Glucoamylase Powder players cover Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), etc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glucoamylase Powder market?
What factors are driving Glucoamylase Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucoamylase Powder market opportunities vary by end market size?
How does Glucoamylase Powder break out by Type, by Application?
This report presents a comprehensive overview of the global Glucoamylase Powder market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Type I (Low Debranching) Glucoamylase Powder
- Type II (High Debranching) Glucoamylase Powder
Segment by Composite Form
- Single Glucoamylase Powder
- Composite Saccharification Powder
Segment by Application
- Feed
- Food
- Brewing
- Other
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Glucoamylase Powder market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Feed, Food, Brewing evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Glucoamylase Powder Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Type I (Low Debranching) Glucoamylase Powder
- 3.1.3 Type II (High Debranching) Glucoamylase Powder
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Feed
- 4.1.3 Food
- 4.1.4 Brewing
- 4.1.5 Other
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Novonesis (CPH: NZYM B, Bagsværd Denmark)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 International Flavors & Fragrances Inc. (NYSE: IFF, New York USA)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Merck KGaA (XTRA: MRK, Darmstadt, Germany)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Amano Enzyme Inc. (TYO: 2802, Aichi Japan)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Enzyme Development Corporation (Unlisted, New York USA)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Creative Enzymes (Unlisted, New York USA)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Enzyme Innovation (Unlisted, Chino California USA)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Murphy & Son Ltd (Unlisted, Nottingham UK)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China)
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Sunsonzyme (Unlisted, Beijing China)
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Henan Yangshao Bio-Engineering Co., Ltd. (Unlisted, Henan China)
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 Longchang Chemical Co., Ltd. (Unlisted, Shandong China)
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Glucoamylase Powder market?
How fast is the Glucoamylase Powder market expected to grow?
What does the Glucoamylase Powder market cover?
How is the Glucoamylase Powder market segmented by type?
What are the key applications of Glucoamylase Powder?
Which companies are profiled in the Glucoamylase Powder market report?
What geographies does the Glucoamylase Powder market analysis include?
What are the key demand drivers for Glucoamylase Powder?
What are the main risks and barriers in the Glucoamylase Powder market?
Who should buy the Glucoamylase Powder market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Glucoamylase Powder Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Chemicals & Advanced Materials